<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70459">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01857141</url>
  </required_header>
  <id_info>
    <org_study_id>4-2011-0904</org_study_id>
    <nct_id>NCT01857141</nct_id>
  </id_info>
  <brief_title>Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of epidural dexmedetomidine decreases the anaesthetic requirements and improved
      postoperative pain. Dexmedetomidine is a potent and highly selective a2-adrenoceptor agonist
      and has sympatholytic effect. Power spectral analysis of heart rate variability(HRV) is a
      useful tool to assess cardiac autonomic activity. We investigated whether preemptive
      epidural dexmedetomidine can develop hemodynamic change and it could be identify patients by
      HRV.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Heart rate variability analysis</measure>
    <time_frame>5min perioids after fluid resuscitation.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heart rate variability analysis was performed according to the Task Force recommendations.
Frequency domain analysis was based on fast Fourier transformation. Power spectrum densities were calculated for low frequencies (LF: 0.04-0.15 Hz) and high frequencies (HF: 0.15-0.4 Hz) informalized units, defined as the LF or HF proportional part of the total power.
Baseline and  30min after the injection of the study drug.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epidural injection</measure>
    <time_frame>at 30 min after the epidural injection of the study drug</time_frame>
    <safety_issue>No</safety_issue>
    <description>And secondary data collection was done at 30 min after the epidural injection of the study drug.
All of the HRV analysis was done before anaesthesia induction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>preemptive dexmedetomidine epidural bolus injection(1.5 mcg/kg)</intervention_name>
    <description>Patients in the pre-emptive groups recived a dose of 1.5㎍/kg dexmedetomidine dissolved into normal saline 10cc before the induction of</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>patients in the control groups received the equivalent volume of normal saline.</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients consented to spinal anesthesia were enrolled

          -  Patients aged 40~70 years olds undergoing gastrectomy

          -  No contraindication of epidural analgesia

          -  ASA class I and II

          -  Patients consented to epidural anesthesia were enrolled

        Exclusion Criteria:

          -  Patients with hypovolemia, coagulation disorders, local infection at the site of
             operation, history of headache, heart diseases, and history of allergy, chronic
             alcohol use or abuse, anemia, congenital heart diseases, bundle block, congestive
             heart failure or arrythmias

          -  patients who had recently received sedative drugs or were under antidepressant
             treatment were not included in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Bajwa SJ, Bajwa SK, Kaur J, Singh G, Arora V, Gupta S, Kulshrestha A, Singh A, Parmar S, Singh A, Goraya S. Dexmedetomidine and clonidine in epidural anaesthesia: A comparative evaluation. Indian J Anaesth. 2011 Mar;55(2):116-21. doi: 10.4103/0019-5049.79883.</citation>
    <PMID>21712865</PMID>
  </reference>
  <reference>
    <citation>Chatzimichali A, Zoumprouli A, Metaxari M, Apostolakis I, Daras T, Tzanakis N, Askitopoulou H. Heart rate variability may identify patients who will develop severe bradycardia during spinal anaesthesia. Acta Anaesthesiol Scand. 2011 Feb;55(2):234-41. doi: 10.1111/j.1399-6576.2010.02339.x. Epub 2010 Nov 8. PubMed PMID: 21058941.</citation>
    <PMID>21058941</PMID>
  </reference>
  <reference>
    <citation>Hanss R, Bein B, Weseloh H, Bauer M, Cavus E, Steinfath M, Scholz J, Tonner PH. Heart rate variability predicts severe hypotension after spinal anesthesia. Anesthesiology. 2006 Mar;104(3):537-45.</citation>
    <PMID>16508402</PMID>
  </reference>
  <reference>
    <citation>Penttilä J, Helminen A, Anttila M, Hinkka S, Scheinin H. Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects. Can J Physiol Pharmacol. 2004 May;82(5):359-62.</citation>
    <PMID>15213737</PMID>
  </reference>
  <reference>
    <citation>Schnaider TB, Vieira AM, Brandão AC, Lobo MV. [Intraoperative analgesic effect of epidural ketamine, clonidine or dexmedetomidine for upper abdominal surgery.]. Rev Bras Anestesiol. 2005 Oct;55(5):525-31. Portuguese.</citation>
    <PMID>19468643</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>May 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>heart rate variability</keyword>
  <keyword>preemptive epidural</keyword>
  <keyword>gastrectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
